AffaMed Therapeutics is a clinical stage therapeutic company that focuses on developing and commercializing pharmaceutical, digital, and surgical products for ophthalmic, neurological, and psychiatric disorders. Their leadership team has extensive experience in discovery, clinical development, regulatory affairs, manufacturing, and business development at leading pharmaceutical companies. The company is dedicated to addressing critical unmet medical needs in Greater China and globally.